These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2386940)

  • 21. Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture.
    Kano Y; Ohnuma T; Okano T; Holland JF
    Cancer Res; 1988 Jan; 48(2):351-6. PubMed ID: 3422052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation of 1-beta-D-arabinofuranosylcytosine cytotoxicity in human tumor cells by inhibiting drug efflux.
    Chan TC
    Cancer Res; 1989 May; 49(10):2656-60. PubMed ID: 2713849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.
    Majlessipour F; Avramis IA; Kwock R; Weinberg KI; Avrami VI
    Anticancer Res; 2002; 22(3):1361-8. PubMed ID: 12168812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of methotrexate and 1-beta-D-arabinofuranosylcytosine on pools of deoxyribonucleoside triphosphates in L1210 ascites cells.
    Roberts D; Peck C
    Cancer Res; 1981 Feb; 41(2):505-10. PubMed ID: 7448798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P; Lien EJ; Avramis VI
    Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S1-phase cells of the leukemic cell cycle sensitive to 1-beta-D-arabinofuranosylcytosine at a high-dose level.
    Smets LA; Homan-Blok J
    Cancer Res; 1985 Jul; 45(7):3113-7. PubMed ID: 4005848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell kinetic studies of the cytostatic and cytocidal effect of 1-beta-D-arabinofuranosylcytosine on the L1210 ascites tumor.
    Fietkau R; Friede H; Maurer-Schultze B
    Cancer Res; 1984 Mar; 44(3):1105-13. PubMed ID: 6692397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of in vitro synergy between etoposide and cis-diamminedichloroplatinum(II).
    Tsai CM; Gazdar AF; Venzon DJ; Steinberg SM; Dedrick RL; Mulshine JL; Kramer BS
    Cancer Res; 1989 May; 49(9):2390-7. PubMed ID: 2706626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined chronochemotherapy of L1210 leukemic mice using 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine, methylprednisolone and cis-diamminedichloroplatinum.
    Scheving LE; Burns ER; Halberg F; Pauly JE
    Chronobiologia; 1980; 7(1):33-40. PubMed ID: 7192203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling of the time-dependency of in vitro drug cytotoxicity and resistance.
    Levasseur LM; Slocum HK; Rustum YM; Greco WR
    Cancer Res; 1998 Dec; 58(24):5749-61. PubMed ID: 9865733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo antileukemic effect of novel dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine.
    Rauko P; Novotny L; Mego M; Saiko P; Schott H; Szekeres T
    Neoplasma; 2007; 54(1):68-74. PubMed ID: 17203895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schedule-dependent interaction of alpha-difluoromethylornithine and cis-diamminedichloroplatinum(II) against human and hamster pancreatic cancer cell lines.
    Chang BK; Gutman R; Chou TC
    Cancer Res; 1987 May; 47(9):2247-50. PubMed ID: 3105873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60).
    Vilpo JA; Vilpo LM
    Cancer Res; 1988 Jun; 48(11):3117-22. PubMed ID: 3163271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM; Rustum YM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
    Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-beta-D-arabinofuranosylcytosine.
    Bergerat JP; Drewinko B; Corry P; Barlogie B; Ho DH
    Cancer Res; 1981 Jan; 41(1):25-30. PubMed ID: 7192598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin.
    Ritch PS; Occhipinti SJ; Cunningham RE; Shackney SE
    Cancer Res; 1981 Oct; 41(10):3881-4. PubMed ID: 7284997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA strand breaks caused by inhibitors of DNA synthesis: 1-beta-D-arabinofuranosylcytosine and aphidicolin.
    Fram RJ; Kufe DW
    Cancer Res; 1982 Oct; 42(10):4050-3. PubMed ID: 6809309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.